Historique de carrière de Charity Scripture
Anciens postes connus de Charity Scripture
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2019 | 23/02/2024 |
| ACELYRIN, INC. | Corporate Officer/Principal | - | - |
Formation de Charity Scripture
| Hamilton College (New York) | Undergraduate Degree |
| Dartmouth Medical School | Graduate Degree |
| University of North Carolina at Chapel Hill | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ACELYRIN, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
- Bourse
- Insiders
- Charity Scripture
- Expérience
